EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, JULY 31, 2019
Media Contacts:
Renee Tessman, [email protected], (612) 928-6137
Angharad Chester-Jones, [email protected], (612) 928-6169
Both Low and High Levels of Hemoglobin Linked to Increased Risk of Dementia
Newswise — MINNEAPOLIS – Having either low or high levels of hemoglobin in your blood may be linked to an increased risk of developing dementia years later, according to a study published in the July 31, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Hemoglobin is the protein in red blood cells responsible for transporting oxygen. Very low hemoglobin is called anemia.
“With around 10 percent of people over age 65 having anemia in the Americas and Europe and up to 45 percent in African and southeast Asian countries, these results could have important implications for the burden of dementia, especially as the prevalence of dementia is expected to increase threefold over the next decades, with the largest increases predicted in the countries where the anemia rate is the highest,” said study author M. Arfan Ikram, PhD, of Erasmus Medical Center in Rotterdam, the Netherlands.
The study involved 12,305 people with an average age of 65 who did not have dementia. Participants’ hemoglobin levels were measured at the start of the study. Overall, 745, or 6 percent, of the participants had anemia.
The participants were followed for an average of 12 years. During that time, 1,520 people developed dementia. Of those, 1,194 had Alzheimer’s disease.
The researchers found that the people with anemia were 41 percent more likely to develop Alzheimer’s disease and 34 percent more likely to develop any type of dementia than those who did not have anemia. Of the 745 people with anemia, 128 developed dementia, compared to 1392 of the 11,560 people who did not have anemia.
People with high levels of hemoglobin were also more likely to develop dementia. High levels can also be a sign of a health problem. The study participants were divided into five groups based on their hemoglobin levels. Compared to the middle group, the group with the highest levels were 20 percent more likely to develop dementia. Those in the lowest group were 29 percent more likely to develop dementia than those in the middle group.
The results stayed the same after researchers adjusted for other factors that could affect the risk of dementia, such as smoking, high blood pressure, high cholesterol and alcohol use.
Ikram noted that the study does not prove that low or high hemoglobin levels are a factor in causing dementia; it only shows an association.
“More research is needed to determine whether hemoglobin levels play a direct role in this increased risk or whether these associations can be explained by underlying issues or other vascular or metabolic changes,” he said.
A limitation of the study was that the participants were primarily of European descent, so the results may not apply to all populations. For example, Ikram noted that a genetic mutation that is common among people of African descent makes people more likely to have anemia, and that the prevalence of malaria and sickle cell disease, which can contribute to anemia, varies around the globe.
The study was supported by the Netherlands Cardiovascular Research Initiative, Erasmus Medical Centre, Erasmus University Rotterdam, Netherlands Organization for Scientific Research, Netherlands Organization for Health Research and Development, Research Institute for Diseases in the Elderly, Netherlands Genomic Initiative, Dutch Ministry of Education, Culture and Science, Dutch Ministry of Health, Welfare and Sports, European Commission, Municipality of Rotterdam, Netherlands Consortium for Healthy Aging and Dutch Heart Foundation.
Learn more about Alzheimer’s disease and dementia at BrainandLife.org, home of the American Academy of Neurology’s free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life® on Facebook, Twitter and Instagram.
The American Academy of Neurology is the world’s largest association of neurologists and neuroscience professionals, with over 36,000 members. The AAN is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer’s disease, stroke, migraine, multiple sclerosis, concussion, Parkinson’s disease and epilepsy.
For more information about the American Academy of Neurology, visit AAN.com or find us on Facebook, Twitter, Instagram, LinkedIn and YouTube.
RSS